Bayer, Onyx Win Expanded Approval of Stomach Cancer Drug

Bayer AG, Germany’s largest drugmaker, and Onyx Pharmaceuticals Inc. won expanded U.S. regulatory approval for a cancer drug to treat patients with a rare type of stomach tumor.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.